progesterone safety pregnancy, progestin birth defects risk, congenital anomalies hormone exposure, 17-hydroxyprogesterone caproate safety, in utero progestin exposure outcomes, pregnancy progesterone teratogenic effects, synthetic progestin fetal development, progesterone supplementation safety data, hydroxyprogesterone pregnancy complications, hormone therapy pregnancy malformations, cohort study progestin exposure, prenatal hormone exposure outcomes
Keywords
17 alpha-Hydroxyprogesterone Caproate, Abnormalities, Drug-Induced/epidemiology, Ethisterone/adverse Effects, Female, Fetal Death/epidemiology, Humans, Hydroxyprogesterones/adverse Effects, Infant, Newborn, Male, Maternal-Fetal Exchange, Medroxyprogesterone/adverse Effects, Minnesota, Norethindrone/adverse Effects, Pregnancy, Prenatal Exposure Delayed Effects, Progesterone/adverse Effects, Progestins/adverse Effects, Hydroxyprogesterones, Progestins, 17 alpha-Hydroxyprogesterone Caproate, Progesterone, Medroxyprogesterone, Ethisterone, Norethindrone,